Logo-bi
Bioimpacts. 2022;12(1): 65-86. doi: 10.34172/bi.2021.23511

Original Research

TEM1-targeting PEGylated PLGA shikonin nanoformulation for immunomodulation and eradication of ovarian cancer

Efthymia-Iliana Matthaiou 1,2 ORCID, Yi Guo 1,3, Jaleh Barar 1,4 ORCID, Raphael Sandaltzopoulos 2, Lana E. Kandalaft 5, Chunsheng Li 1 * , George Coukos 1,5, Yadollah Omidi 1,6 * ORCID

Cited by CrossRef: 0



BioImpacts, as a peer-reviewed international journal, publishes all types of papers on bench-to-bedside translational aspects of pharmaceutical and biomedical sciences. As a "Publish Free" and "Access Free" journal, BioImpacts follows a constructive peer-review process with free editing service to benefit the scientific community worldwide.